Determination of itraconazole in human plasma by high-performance liquid chromatography with solid-phase extraction

Annals of Clinical Biochemistry

Volumn 42, Issue 2, 2005, Pages 94-98

  Ohkubo, Tadashi ^a   Osanai, Takako ^a  

^a HIROSAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIFONAZOLE; ITRACONAZOLE;

ACCURACY; ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 17144383647     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053492711     Document Type: Article

References (27)

1. Boogaerts M, Maertens J. Clinical experience with itraconazole in systemic fungal infection. Drugs 2001; 61(Suppl 1): 39-47
2. De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs 2001; 61(Suppl 1): 27-37
3. Schmitt HJ, Edwards F, Andrade J, Niki Y, Armstrong D. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis. Chemotherapy 1992; 38: 118-26
4. Meis JFGM, Verweij PE. Current management of fungal infection. Drugs 2001; 61 (Suppl 1): 13-55
5. Poirier J-M, Cheymol G. Optimisation of itraconazole therapy using target drug concentrations. Clin Pharmacokinet 1998; 35: 461-73
6. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of antifungal agents on oxidative drug metabolism. Clin Pharmacokinet 2000; 38: 111-80
7. Hardin TC, Graybill JR, Fetchick R, Woestenborghs R, Rinaldi MG, Kuhn JG. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988; 32: 1310-3
8. Badcock NR. Micro-scale method for itraconazole in plasma by reversed-phase high-performance liquid chromatography. J Chromatgr B 1990; 525: 478-83
9. Cox SK, Orosz S, Burnette J, Frazier D. Microassay for determination of itraconazole and hydroxyitraconazole in plasma and tissue biopsies. J Chromatogr B 1997; 702: 175-80
10. Gubbins PO, Gurley BJ, Bowman J. Rapid and sensitive high performance liquid chromatographic determination of itraconazole and its hydroxyl-metabolite in human serum. J Pharm Biomed Anal 1998; 16: 1005-12
11. Al-Rawithi S, Hussein R, Al-Moshen I, Raines D. Expedient microdetermination of itraconazole and hydroxyitraconazole in plasma by high-peformance liquid chromatography with fluorescence detection. Ther Drug Monit 2001; 23: 445-8
12. Woestenborghs R, Lorreyne W, Heykants J. Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr B 1987; 413: 332-7
13. Poirier J-M, Lebot M, Descamps P, Levy M, Cheymol G. Determination of itraconazole and its active metabolite in plasma by column liquid chromatography. Ther Drug Monit 1994; 16: 596-601
14. Compas D, Touw DJ, de Goede PNFC. Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography. J Chromatogr B 1996; 687: 453-6
15. Remmel RP, Dombrovskis D, Canafax DM. Assay of itraconazole in leukemic patient plasma by reversed-phase small-bore liquid chromatography. J Chromatogr B 1988; 432: 388-94
16. Brandšteterová E, Kubalec P, Rády A, Krèmíry V. Determination of itraconazole and its metabolite in plasma using SPE-HPLC. Pharmazie 1995; 50: 597-9
17. Refai N, Sakamoto M, Platt O, Brugnara C. A high-performance liquid chromatographic assay for the determination of itraconazole concentration using solid-phase extraction and small sample volume. Ther Drug Monit 1995; 17: 522-5
18. Koks CHW, Sparidans RW, Lucassen G, Crommentuyn KML, Beijnen JH. Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients. J Chromatorg B 2002; 767: 103-10
19. Kubalec P, Brandšteterová E. Column-switching chromatographic determination of itraconazole and its metabolite hydroxylitraconazole in human serum. Pharmazie 2001; 56: 397-400
20. Carrier A, Parent J. Liquid chromatographic-mass spectrometric determination of itraconazole and its major metabolite, hydroxyitraconazole, in dog plasma. J Chromatogr B 2000; 745: 413-20
21. Nagasaki T, Ohkubo T, Yasui N, Otani K, Kaneko S. High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection. J Chromatogr B 1998; 714: 293-8
22. Nagasaki T, Ohkubo T, Yasui N, Furukori H, Kaneko S. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia. J Pharm Biomed Anal 1999; 19: 595-601
23. Shimoyama R, Ohkubo T. Characteristic of interaction between barbiturate derivatives and various sorbents on liquid chromatography and determination of phenobarbital in Japanese human breast milk. J Liquid Chromatogr Relat Technol 2000; 23: 587-99
24. Shimiyama R, Ohkubo T. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 2000; 37: 210-5
25. Bradford CR, Prentice AG, Warnok DW, Copplestone JA. Comparison of the multiple dose pharmacokinetics of two formulation of itraconazole during remission induction for acute myeloblastic leukemia. J Antimicrob Chemother 1991; 28: 555-60
26. Jaruratanasirikul S, Sriwiriyajan S. Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol 1998; 54: 159-61
27. Yeates RA, Zimmermann T, Laufen H, Albrecht M, Wildfeuer A. Comparative pharmacokinetics of fluconazole and of itraconazole in Japanese and in German subjects. Int J Clin Pharmacol Ther 1995; 33: 131-5